TWA
EGRX
TCI Wealth Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-119
| Closed | -$3.48K | – | 2664 |
|
|
2022
Q4 | $3.48K | Sell |
119
-18
| -13% | -$526 | ﹤0.01% | 1770 |
|
|
2022
Q3 | $4K | Buy |
137
+39
| +40% | +$1.14K | ﹤0.01% | 1707 |
|
|
2022
Q2 | $4K | Buy |
+98
| New | +$4K | ﹤0.01% | 1730 |
|
|
2018
Q4 | – | Sell |
-14
| Closed | -$1K | – | 1694 |
|
|
2018
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 1357 |
|
|
2018
Q2 | $1K | Hold |
14
| – | – | ﹤0.01% | 1412 |
|
|
2018
Q1 | $1K | Hold |
14
| – | – | ﹤0.01% | 1255 |
|
|
2017
Q4 | $1K | Hold |
14
| – | – | ﹤0.01% | 1295 |
|
|
2017
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 1227 |
|
|
2017
Q2 | $1K | Hold |
14
| – | – | ﹤0.01% | 1250 |
|
|
2017
Q1 | $1K | Hold |
14
| – | – | ﹤0.01% | 1198 |
|
|
2016
Q4 | $1K | Hold |
14
| – | – | ﹤0.01% | 1264 |
|
|
2016
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 1252 |
|
|
2016
Q2 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 1185 |
|